Related Experiment Videos

Palliative care in the cancer patient

Journal of the American Geriatrics Society

|September 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2006

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.

Annals of oncology : official journal of the European Society for Medical Oncology·2005

Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

European journal of cancer (Oxford, England : 1990)·2003

Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.

Bone marrow transplantation·2002

See all related articles